Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phil Lieberman

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
The World Allergy Organization Journal|December 5, 2015
Risk multipliers for severe food anaphylaxisPeter K Smith, Jonathan O'B Hourihane, Phil Lieberman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2018
The changing face of anaphylaxis in adults and adolescentsDebendra Pattanaik, Phil Lieberman, Jay Lieberman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 7, 2018
Value of a Second Dose of Epinephrine During Anaphylaxis: A Patient/Caregiver SurveyT Ted Song, Duncan Brown, Martin Karjalainen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Anaphylaxis care guidelines and the effect on health care resource use in the United StatesT Ted Song, Duncan Brown, Ulrike Lehnigk, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 13, 2019
Idiopathic anaphylaxis yardstick: Practical recommendations for clinical practiceMelody C Carter, Cem Akin, Mariana C Castells, et al.
Allergy and Asthma Proceedings|March 1, 2011
Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitisPhil Lieberman, Eli O Meltzer, Craig F LaForce, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitisWilliam E Berger, Shailen Shah, Phil Lieberman, et al.
The Journal of Allergy and Clinical Immunology|March 16, 2012
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitisWarner Carr, Jonathan Bernstein, Phil Lieberman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 15, 2006
Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working GroupPhil Lieberman, Carlos A Camargo, Kari Bohlke, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 10, 2006
Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and ImmunologyLeonard Bielory, Michael Blaiss, Stanley M Fineman, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
The World Allergy Organization Journal|December 5, 2015
Risk multipliers for severe food anaphylaxisPeter K Smith, Jonathan O'B Hourihane, Phil Lieberman
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2018
The changing face of anaphylaxis in adults and adolescentsDebendra Pattanaik, Phil Lieberman, Jay Lieberman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 7, 2018
Value of a Second Dose of Epinephrine During Anaphylaxis: A Patient/Caregiver SurveyT Ted Song, Duncan Brown, Martin Karjalainen, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 24, 2018
Anaphylaxis care guidelines and the effect on health care resource use in the United StatesT Ted Song, Duncan Brown, Ulrike Lehnigk, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 13, 2019
Idiopathic anaphylaxis yardstick: Practical recommendations for clinical practiceMelody C Carter, Cem Akin, Mariana C Castells, et al.
Allergy and Asthma Proceedings|March 1, 2011
Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitisPhil Lieberman, Eli O Meltzer, Craig F LaForce, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 11, 2014
Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitisWilliam E Berger, Shailen Shah, Phil Lieberman, et al.
The Journal of Allergy and Clinical Immunology|March 16, 2012
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitisWarner Carr, Jonathan Bernstein, Phil Lieberman, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 15, 2006
Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working GroupPhil Lieberman, Carlos A Camargo, Kari Bohlke, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 10, 2006
Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and ImmunologyLeonard Bielory, Michael Blaiss, Stanley M Fineman, et al.
Pageof 6